Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Ginseng bleeding case reports exist on antithrombotic therapy overall; on antiplatelets the documented concern is low-grade. The cited anchor is the warfarin-by-ginseng interaction RCT; on antiplatelets the borrowing is class-level context, not a trial of this pair.
Evidence tier: mechanistic
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Tell your doctor about ginseng use.
- Watch for bleeding signs.
← All reviewed pairs for Antiplatelets (aspirin, clopidogrel)